Forno E, Fuhlbrigge A, Soto-Quiró s ME, et al. Chest. 2010;138(5):1156 -1165 PURPOSE OF THE STUDY. To develop and verify a clinical score to be used by primary care providers to identify children at high risk of exacerbation.
RESULTS. Multivariate analysis in the validation set showed that each 1-point increment in the clinical score was associated with a 1.6-fold increase in the risk for an exacerbation. Relative to children at average risk, the odds ratio for an exacerbation was 0.2 (95% confidence interval [CI] : 0.1-0.4) among children in the low-risk group and 5.4 (95% CI: 1.5-19.2) among children in the high-risk group. Comparable results were obtained from the CAMP cohort. Compared with children at average risk for an exacerbation, the hazard ratios for exacerbations among children in the low-and high-risk groups were 0.6 (95% CI: 0.5-0.7) and 1.9 (95% CI: 1.4 -2.4), respectively, at 1-year follow-up, and there were similar results at 2 years.
CONCLUSIONS. The asthma clinical score yielded consistent results in the exploratory and validation sets, which indicates good reproducibility. The scoring system shows potential as a simple diagnostic tool that can easily be used in primary care settings worldwide.
REVIEWER COMMENTS. Although the exclusion of pulmonaryfunction data might seem like a limiting factor of the study, many primary care providers do not have access to pulmonary-function testing results. The goal of this study was to create a useful clinical tool that could predict exacerbations in the absence of pulmonary-function or laboratory data. The practical usefulness of the proposed scoring system depends on its simplicity and clarity. The results of this study demonstrate the development of a simple clinical score that effectively identifies children at high risk for exacerbations. Additional studies among different cohorts are needed to fine-tune the score and evaluate its practical usefulness as a diagnostic tool in primary care settings. METHODS. This was a retrospective cohort analysis. The sponsor parent's race and ethnicity were used as a proxy for the child's race and ethnicity. Outcome measures included the prevalence of diagnosed asthma (using International Classification of Diseases, Ninth Revision [ICD-9] codes), "potentially avoidable" asthma hospitalizations, asthma-related emergency department visits, visits to asthma specialists, and use of asthma medications among children 2 to 4, 5 to 10, and 11 to 17 years of age. CONCLUSIONS. Despite universal health insurance coverage offered through the MHS, the authors found evidence of racial and ethnic differences in asthma prevalence, treatment, and outcomes.
REVIEWER COMMENTS. This study corroborates the presence of racial and ethnic disparities in asthma within a cohort offered universal health care coverage. Black children were not only more likely to be diagnosed with asthma, but they were also found to have poorer control of asthma. It was surprising that black children were also more likely to have filled prescriptions for inhaled steroids compared with white children. The authors suggested that the higher rates of filled prescriptions might be attributed to the higher likelihood of receiving these prescriptions for asthma medications during and after emergency department visits and/or hospitalizations. Actual use and administration of these medications were not evaluated. The study's findings suggest that eliminating racial and ethnic disparities in health care likely requires a multifaceted approach beyond universal health insurance coverage. To determine the prevalence of uncontrolled asthma by using validated instruments in a representative sample of pediatric primary care offices.
STUDY POPULATION. Patients were recruited from pediatric outpatient offices across the United States. Eligible patients for this study included children who were between the ages of 4 and 17 years, had a history of asthma as diagnosed by a heath care provider, used an asthma medication in the previous year, and were able to read, write, and comprehend English.
METHODS. This was a multisite cross-sectional study of patients with asthma who visited a pediatric health care provider for any reason between January and May 2008. The questionnaires given to the patients included the Childhood Asthma Control Test (C-ACT) for those between the ages of 4 and 11 years and the Asthma Control Test (ACT) for those between the ages of 12 and 17 years. Uncontrolled asthma was defined as a C-ACT or ACT score of Ͻ19. Each visit was also classified as either respiratory-or non-respiratory-related.
RESULTS. The overall prevalence of uncontrolled asthma was 46% (35% in patients with nonrespiratory complaints and 54% among those seen for a respiratory complaint). For patients evaluated for respiratory reasons, more children with uncontrolled asthma had missed Ն1 school day in the previous 4 weeks because of asthma (67% vs 29%; P Ͻ .0001). For patients seen for nonrespiratory reasons, more children with uncontrolled asthma had missed Ն1 day of school in the previous 4 weeks (53% vs 24%; P Ͻ .0001).
CONCLUSIONS. The number of missed school and work days resulting from uncontrolled asthma was not only greater for patients seen in a pediatric office for respiratoryrelated issues but also for non-respiratory-related reasons. This result highlights the burden and impact of uncontrolled asthma seen in all patients in pediatric clinics. Providers should consider evaluating asthma control on a regular basis regardless of the reason for the visit.
REVIEWER COMMENTS. The ACT and C-ACT tools were designed to use only for children already diagnosed with asthma. The cutoff score of Յ19 is not an absolute indicator of uncontrolled asthma but should serve to alert the provider that asthma might not be well controlled. A report of using C-ACT scores to identify children with very poorly controlled asthma has been published previously (J Allergy Clin Immunol. 2010; 126[2]:267-273 
